Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M. Sathyanarayana P, et al. Among authors: samson sl. Obesity (Silver Spring). 2011 Dec;19(12):2310-5. doi: 10.1038/oby.2011.152. Epub 2011 Jun 9. Obesity (Silver Spring). 2011. PMID: 21660077 Clinical Trial.
Gene therapy for diabetes: reinventing the islet.
Samson SL, Chan L. Samson SL, et al. Trends Endocrinol Metab. 2006 Apr;17(3):92-100. doi: 10.1016/j.tem.2006.02.002. Epub 2006 Feb 28. Trends Endocrinol Metab. 2006. PMID: 16504534 Review.
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia.
Samson SL, Pownall HJ, Scott LW, Ballantyne CM, Smith EO, Sekhar RV, Balasubramanyam A. Samson SL, et al. Contemp Clin Trials. 2006 Dec;27(6):518-30. doi: 10.1016/j.cct.2006.07.002. Epub 2006 Jul 21. Contemp Clin Trials. 2006. PMID: 16914390 Clinical Trial.
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
Samson SL, Gonzalez EV, Yechoor V, Bajaj M, Oka K, Chan L. Samson SL, et al. Mol Ther. 2008 Nov;16(11):1805-12. doi: 10.1038/mt.2008.198. Epub 2008 Sep 9. Mol Ther. 2008. PMID: 18781141 Free PMC article.
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice.
Yechoor V, Liu V, Paul A, Lee J, Buras E, Ozer K, Samson S, Chan L. Yechoor V, et al. Among authors: samson s. Endocrinology. 2009 Nov;150(11):4863-73. doi: 10.1210/en.2009-0527. Epub 2009 Oct 9. Endocrinology. 2009. PMID: 19819964 Free PMC article.
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.
Samson SL, Sathyanarayana P, Jogi M, Gonzalez EV, Gutierrez A, Krishnamurthy R, Muthupillai R, Chan L, Bajaj M. Samson SL, et al. Diabetologia. 2011 Dec;54(12):3093-100. doi: 10.1007/s00125-011-2317-z. Epub 2011 Sep 29. Diabetologia. 2011. PMID: 21956711 Free PMC article. Clinical Trial.
Potential of incretin-based therapies for non-alcoholic fatty liver disease.
Samson SL, Bajaj M. Samson SL, et al. J Diabetes Complications. 2013 Jul-Aug;27(4):401-6. doi: 10.1016/j.jdiacomp.2012.12.005. Epub 2013 Jan 24. J Diabetes Complications. 2013. PMID: 23352496 Review.
GLP-1R agonist therapy for diabetes: benefits and potential risks.
Samson SL, Garber A. Samson SL, et al. Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):87-97. doi: 10.1097/MED.0b013e32835edb32. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 23403741 Review.
HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation.
Agarwal N, Iyer D, Patel SG, Sekhar RV, Phillips TM, Schubert U, Oplt T, Buras ED, Samson SL, Couturier J, Lewis DE, Rodriguez-Barradas MC, Jahoor F, Kino T, Kopp JB, Balasubramanyam A. Agarwal N, et al. Among authors: samson sl. Sci Transl Med. 2013 Nov 27;5(213):213ra164. doi: 10.1126/scitranslmed.3007148. Sci Transl Med. 2013. PMID: 24285483 Free PMC article.
Cardiovascular effects of incretin therapy in diabetes care.
Kim J, Samson SL. Kim J, et al. Among authors: samson sl. Metab Syndr Relat Disord. 2014 Aug;12(6):303-10. doi: 10.1089/met.2014.0035. Epub 2014 May 19. Metab Syndr Relat Disord. 2014. PMID: 24842063 Free PMC article. Review.
80 results
Jump to page
Feedback